TY - JOUR
T1 - Novel treatment approaches to cachexia and sarcopenia: Highlights from the 5th Cachexia Conference
AU - Kung, Thomas
AU - Springer, Jochen
AU - Doehner, Wolfram
AU - Anker, Stefan D.
AU - von Haehling, Stephan
PY - 2010
Y1 - 2010
N2 - Cachexia is an illness that may occur in terminal stages of many chronic illnesses including cancer, chronic heart failure, chronic renal failure or chronic obstructive pulmonary disease. Effective treatments are urgently needed in order to improve the patients' quality of life and their survival. We report highlights from the 5th Cachexia Conference held in December 2009 in Barcelona, Spain. Novel therapeutic approaches shown here include melanocortin-4 receptor antagonists, myostatin inhibition, beta-blockers, IL-6 antagonism synthetic ghrelin and vitamin D.
AB - Cachexia is an illness that may occur in terminal stages of many chronic illnesses including cancer, chronic heart failure, chronic renal failure or chronic obstructive pulmonary disease. Effective treatments are urgently needed in order to improve the patients' quality of life and their survival. We report highlights from the 5th Cachexia Conference held in December 2009 in Barcelona, Spain. Novel therapeutic approaches shown here include melanocortin-4 receptor antagonists, myostatin inhibition, beta-blockers, IL-6 antagonism synthetic ghrelin and vitamin D.
U2 - 10.1517/13543781003724690
DO - 10.1517/13543781003724690
M3 - Article
VL - 19
SP - 579
EP - 585
JO - Expert Opinion on Investigational Drugs
JF - Expert Opinion on Investigational Drugs
SN - 1354-3784
IS - 4
ER -
